Skip to content
MIT Science Policy Review

MIT Science Policy Review

MIT Science Policy Review
  • Article Categories
    • AI
    • Climate Change
    • Healthcare
    • Science Enterprise
    • Space & Security
  • Volumes
    • Volume I, December 2020
    • Volume II, August 2021
    • Volume III, August 2022
  • Our Organization
    • About
    • Leadership
    • Editorial Board
    • Advisory Board
    • Sponsors
  • Contact
    • Contact Us
    • Subscribe
    • Write For Us
MIT Science Policy Review
  • Artificial Intelligence
  • Climate Change & Energy
  • Healthcare
  • Science Enterprise
  • Space & Security

Category: Healthcare

Healthcare

The next frontier of combating drug addiction in America

Cole Korponay

Evidence-based policies and new technologies may help the U.S. in the future of combating drug addiction.

View More The next frontier of combating drug addiction in America
Healthcare

The past, present, and future of human challenge trials

Anna M. Romanov , and Jeongpyo Hong

Scientific, ethical, and regulatory considerations are key when designing human challenge trials.

View More The past, present, and future of human challenge trials
Healthcare

The future of treating aging

Krystle Kalafut3 Morgan Janes , and Francesca Riccio-Ackerman

As our population ages, our medical institutions may need to re-evaluate the status quo.

View More The future of treating aging
Healthcare

Biogen’s Aduhelm controversy as a case study for accelerated approval biomarkers in Alzheimer’s and related diseases

Alex Berg3 Ryan P. Mayers , and Sarah Richards

The recent FDA Biogen controversy sheds light on the future of drug approval in America.

View More Biogen’s Aduhelm controversy as a case study for accelerated approval biomarkers in Alzheimer’s and related diseases
Healthcare Space & Security

Biosecurity risks and governance in the age of synthetic biology

Jon Arizti Sanz3 Garrett Dunlap3 Nicholas Nolan , and 1 more

The rapid pace of biotechnology development poses real and alarming biosecurity risks.

View More Biosecurity risks and governance in the age of synthetic biology

Posts navigation

Page 1 Page 2 Page 3 Next page

Recent Articles

Healthcare

The next frontier of combating drug addiction in America

Cole Korponay

Evidence-based policies and new technologies may help the U.S. in the future of combating drug addiction.

Climate Change & Energy

Methane emissions and global warming: Mitigation technologies, policy ambitions, and global efforts

William J. Sawyer3 Islam Genina3 Rebecca J. Brenneis , and 3 more

Reducing global methane emissions may require technology development, proven policies, and private-public sector collaboration.

Science Enterprise

Whither Section 230? – Law and disruptive technology

John L. Akula

The U.S. court system is set to impact the future of Section 230 policy debate.

Content

  • AI
  • Climate Change
  • Healthcare
  • Science Enterprise

Resources

  • Our Organization
  • Leadership
  • Editorial Board
  • Advisory Board
  • Subscribe
  • Pitch an Article
  • Contact Us

Disclaimer

The views and opinions expressed are solely those of the authors and do not reflect the official position of MIT or the MIT Science Policy Review.

  • Licenses & Copyright

Follow us

Visit Us On TwitterVisit Us On FacebookVisit Us On Linkedin
MIT Science Policy Review | Designed by: Theme Freesia | WordPress | © Copyright All right reserved